Trial intelligence / Profile preview

Duloxetine for Post-thoracotomy Pain

NCT03618225Phase 4Completed

Sponsor
Assiut University
Start
Aug 2018
Primary completion
Jan 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in post-thoracotomy pain syndrome (PTPS) comparing Duloxetine group with Placebo group (2 arms). Primary endpoint: Total dose of morphine needed to treat postoperative pain at 48 hours. Started Aug 2018; status: completed.

02

Drugs

duloxetine
03

Conditions

post-thoracotomy pain syndrome (PTPS)

Beyond the preview

Go deeper on NCT03618225.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03618225.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call